These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38994962)

  • 1.
    Hamwi MN; Elsayed E; Dabash H; Abuawad A; Aweer NA; Al Zeir F; Pedersen S; Al-Mansoori L; Burgon PG
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of MLIP (muscle-enriched A-type lamin-interacting protein) leads to cardiac hyperactivation of Akt/mammalian target of rapamycin (mTOR) and impaired cardiac adaptation.
    Cattin ME; Wang J; Weldrick JJ; Roeske CL; Mak E; Thorn SL; DaSilva JN; Wang Y; Lusis AJ; Burgon PG
    J Biol Chem; 2015 Oct; 290(44):26699-714. PubMed ID: 26359501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of murine muscle-enriched A-type lamin-interacting protein (MLIP) is regulated by tissue-specific alternative transcription start sites.
    Cattin ME; Deeke SA; Dick SA; Verret-Borsos ZJA; Tennakoon G; Gupta R; Mak E; Roeske CL; Weldrick JJ; Megeney LA; Burgon PG
    J Biol Chem; 2018 Dec; 293(51):19761-19770. PubMed ID: 30389785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLIP causes recessive myopathy with rhabdomyolysis, myalgia and baseline elevated  serum creatine kinase.
    Lopes Abath Neto O; Medne L; Donkervoort S; Rodríguez-García ME; Bolduc V; Hu Y; Guadagnin E; Foley AR; Brandsema JF; Glanzman AM; Tennekoon GI; Santi M; Berger JH; Megeney LA; Komaki H; Inoue M; Cotrina-Vinagre FJ; Hernández-Lain A; Martin-Hernández E; Williams L; Borell S; Schorling D; Lin K; Kolokotronis K; Lichter-Konecki U; Kirschner J; Nishino I; Banwell B; Martínez-Azorín F; Burgon PG; Bönnemann CG
    Brain; 2021 Oct; 144(9):2722-2731. PubMed ID: 34581780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle Enriched Lamin Interacting Protein (
    Ahmady E; Blais A; Burgon PG
    Cells; 2021 Mar; 10(3):. PubMed ID: 33802236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities.
    Zhang C; Zhang F
    Protein Cell; 2015 Feb; 6(2):88-100. PubMed ID: 25476483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer.
    Akbarzadeh M; Mihanfar A; Akbarzadeh S; Yousefi B; Majidinia M
    Life Sci; 2021 Nov; 285():119984. PubMed ID: 34592229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of non-coding RNAs in the regulation of PI3K/AKT pathway in the carcinogenesis process.
    Ghafouri-Fard S; Abak A; Tondro Anamag F; Shoorei H; Majidpoor J; Taheri M
    Biomed Pharmacother; 2021 May; 137():111279. PubMed ID: 33493969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxO transcription factors in cancer metabolism.
    Yadav RK; Chauhan AS; Zhuang L; Gan B
    Semin Cancer Biol; 2018 Jun; 50():65-76. PubMed ID: 29309929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel muscle A-type lamin-interacting protein (MLIP).
    Ahmady E; Deeke SA; Rabaa S; Kouri L; Kenney L; Stewart AF; Burgon PG
    J Biol Chem; 2011 Jun; 286(22):19702-13. PubMed ID: 21498514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nuclear EGFR: a new mode of oncogenic signalling in cancer].
    Gazzeri S
    Biol Aujourdhui; 2018; 212(1-2):27-33. PubMed ID: 30362453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.
    Morrison AJ
    FEBS J; 2022 Mar; 289(5):1302-1314. PubMed ID: 34036737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic truncating variants in the muscular A-type lamin-interacting protein (MLIP) gene cause myopathy with hyperCKemia.
    Salzer-Sheelo L; Fellner A; Orenstein N; Bazak L; Lev-El Halabi N; Daue M; Smirin-Yosef P; Van Hout CV; Fellig Y; Ruhrman-Shahar N; Staples J; Magal N; Shuldiner AR; Mitchell BD; Nevo Y; Pollin TI; Gonzaga-Jauregui C; Basel-Salmon L
    Eur J Neurol; 2022 Apr; 29(4):1174-1180. PubMed ID: 34935254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-evaluating the role of FOXOs in cancer.
    Hornsveld M; Dansen TB; Derksen PW; Burgering BMT
    Semin Cancer Biol; 2018 Jun; 50():90-100. PubMed ID: 29175105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer.
    Lien EC; Lyssiotis CA; Cantley LC
    Recent Results Cancer Res; 2016; 207():39-72. PubMed ID: 27557534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging roles of ARID1A in tumor suppression.
    Wu RC; Wang TL; Shih IeM
    Cancer Biol Ther; 2014 Jun; 15(6):655-64. PubMed ID: 24618703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness.
    Ma Y; Shen N; Wicha MS; Luo M
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXO family in regulating cancer and metabolism.
    Ma J; Matkar S; He X; Hua X
    Semin Cancer Biol; 2018 Jun; 50():32-41. PubMed ID: 29410116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression.
    Pandya DV; Parikh RV; Gena RM; Kothari NR; Parekh PS; Chorawala MR; Jani MA; Yadav MR; Shah PA
    Mol Biol Rep; 2024 Jun; 51(1):701. PubMed ID: 38822973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeostasis and the importance for a balance between AKT/mTOR activity and intracellular signaling.
    Altomare DA; Khaled AR
    Curr Med Chem; 2012; 19(22):3748-62. PubMed ID: 22680924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.